Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.82 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.82 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.82 |
| ▸ | KMT2A | Q03164 | 13/20 | 0.81 |
| ▸ | MEN1 | O00255 | 12/20 | 0.81 |
| ▸ | POLB | P06746 | 2/20 | 0.81 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.71 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.71 |
| ▸ | AKT1 | P31749 | 1/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.69 |
| ▸ | PKM | P14618 | 1/20 | 0.69 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.68 |
| ▸ | HPGD | P15428 | 2/20 | 0.67 |
| ▸ | GBA1 | P04062 | 1/20 | 0.67 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13212141 | 0.89 | KMT2A (1.00) | ALDH1A1TDP1ALOX12KMT2AMEN1 | |
| SCHEMBL31058614 | 0.89 | KMT2A (0.81) | ALDH1A1TDP1ALOX12KMT2AMEN1 | |
| SCHEMBL5401402 | 0.87 | ALDH1A1 (1.00) | ALDH1A1TDP1ALOX12KMT2AMEN1 | |
| SCHEMBL30209719 | 0.85 | MEN1 (0.82) | ALDH1A1TDP1ALOX12KMT2AMEN1 | |
| SCHEMBL14420720 | 0.85 | MEN1 (0.80) | ALDH1A1KMT2AMEN1POLBAKT1 | |
| SCHEMBL13212124 | 0.83 | KMT2A (0.80) | ALDH1A1TDP1ALOX12KMT2AMEN1 | |
| SCHEMBL287025 | 0.83 | AKT1 (1.00) | ALDH1A1KMT2AMEN1POLBAKT1 | |
| SCHEMBL13212128 | 0.83 | MEN1 (1.00) | ALDH1A1TDP1ALOX12KMT2AMEN1 | |
| SCHEMBL11893078 | 0.82 | AKT1 (0.80) | ALDH1A1KMT2AMEN1POLBAKT1 | |
| SCHEMBL14332232 | 0.81 | GBA1 (1.00) | ALDH1A1TDP1ALOX12KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 439 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4692104-A1 | CONJUGATE OF ANTIBODY AND FUNCTIONAL SUBSTANCE OR SALT OF SAID CONJUGATE, AND ANTIBODY INTERMEDIATE HAVING THIOL GROUP OR SALT OF SAID ANTIBODY INTERMEDIATE | AJINOMOTO CO., INC. (JP) | 2026-02-11 | — | — | EP | claimed |
| CN-119909064-A | Cystamine derivative or salt thereof and application thereof in preparation of medicines with antioxidation effect | 北京大学深圳研究生院 | 2025-05-02 | — | — | CN | claimed |
| CN-119338077-B | Wind turbine running state prediction method and prediction system | 四川省能投美姑新能源开发有限公司 | 2025-04-08 | — | — | CN | claimed |
| CN-119338077-A | Wind turbine running state prediction method and prediction system | 四川省能投美姑新能源开发有限公司 | 2025-01-21 | — | — | CN | claimed |
| CN-118909706-A | Process for finely brewing beer by millet | 鲁东大学 | 2024-11-08 | — | — | CN | claimed |
| CN-118879427-A | Novel alcohol-free beer brewing process | 鲁东大学 | 2024-11-01 | — | — | CN | claimed |
| CN-111511079-B | Strobe-free dimming driver utilizing input valley bottom compensation | 浙江凯耀照明有限责任公司 | 2024-10-29 | — | — | CN | claimed |
| WO-2024210178-A1 | CONJUGATE OF ANTIBODY AND FUNCTIONAL SUBSTANCE OR SALT OF SAID CONJUGATE, AND ANTIBODY INTERMEDIATE HAVING THIOL GROUP OR SALT OF SAID ANTIBODY INTERMEDIATE | 味の素株式会社 | 2024-10-10 | — | — | WO | claimed |
| US-20240251664-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-07-25 | — | — | US | claimed |
| CN-118234088-A | Automatic temperature control circuit of LED lamp | 宁波凯耀电器制造有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-217470334-U | Time-delay turn-off circuit | 宁波凯耀电器制造有限公司 | 2022-09-20 | — | — | CN | claimed |
| CN-217160060-U | Color temperature switching de-pulsing circuit | 宁波凯耀电器制造有限公司 | 2022-08-09 | — | — | CN | claimed |
| CN-216902800-U | Excimer lamp exciter for solving EMI | 浙江凯耀照明有限责任公司 | 2022-07-05 | — | — | CN | claimed |
| CN-114597115-A | Excimer lamp exciter for solving EMI | 浙江凯耀照明有限责任公司 | 2022-06-07 | — | — | CN | claimed |
| CN-114567174-A | IC current electric measurement compensation circuit and application circuit thereof | 浙江凯耀照明有限责任公司 | 2022-05-31 | — | — | CN | claimed |
| US-20070066614-A1 | Ihibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | BIOVITRUM AB | 2007-03-22 | — | — | US | claimed |
| US-7173030-B2 | Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 | BIOVITRUM AB (SE) | 2007-02-06 | — | — | US | claimed |
| EP-1631558-A1 | INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE I | BIOVITRUM AB (SE) | 2006-03-08 | — | — | EP | claimed |
| US-20050009821-A1 | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | BIOVITRUM AB | 2005-01-13 | — | — | US | claimed |
| WO-2004103980-A1 | INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE I | BIOVITRUM AB (SE) | 2004-12-02 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009821-A1 | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | HSD11B1, HSD17B1, HSD11B2 | ALDH1A1 53/4885TDP1 926/4885ALOX12 366/4885 |
| US-20240251664-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | NES, NFE2L2, NUCB2 | ALDH1A1 264/4885TDP1 2312/4885ALOX12 1405/4885 |
| US-20070066614-A1 | Ihibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | HSD11B1, HSD17B1, HSD17B11 | ALDH1A1 36/4885TDP1 1572/4885ALOX12 736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.